# Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction

> **NCT00174486** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 300 (—)

## Conditions studied

- Impotence

## Interventions

- **DRUG:** UK0369,003
- **DRUG:** Cialis (Tadalafil)

## Key facts

- **NCT ID:** NCT00174486
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 300 (—)
- **Last updated:** 2006-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174486, "Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00174486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*